GeneNews™

This company was founded in 1998. It was established to focus on the identification of novel therapeutic aims for a single disease, osteoarthritis. At that time, the company was devoting to the gene expression of cartilage cells called chondrocytes, hence the name ChondroGene. The target was to examine how the tissues of the joint function in different stages of osteoarthritis; from normal joints, to moderately diseased joints, all the way to severe osteoarthritis which can be treated only by total joint replacement.

Later, they made gene-based tests and the genomic information gained from their discovery pipeline will provide a continuing stream of novel information  across a broad range of diseases and clinical questions. Due to these conclusions, the company decided to change its’ name to GeneNews.

The diagnostic areas are: Colon Cancer, Lung Cancer, Prostate Cancer and Breast Cancer.